Dr. Rao says brain AVM care should be personalized

USA-trained neurosurgeon Dr. Mohana Rao Patibandla is urging patients and families to think beyond open surgery when a brain arteriovenous malformation is diagnosed. His message: the right treatment depends on the lesion, the patient and a multidisciplinary review, with precision radiosurgery expanding options for carefully selected cases.

Why it matters: - Brain arteriovenous malformations can cause seizures, headaches or life-threatening hemorrhage, and treatment decisions can shape long-term neurological function. - Dr. Mohana Rao Patibandla says modern AVM care is shifting toward individualized, evidence-based planning rather than a one-size-fits-all surgery-first approach. - Patients may now have more options, including microsurgery, endovascular embolization, stereotactic radiosurgery and, in some cases, observation.

What happened: - Dr. Rao, founder and chief neurosurgeon at Dr. Rao's Hospital – International Institute of Neurosciences in Guntur, Andhra Pradesh, India, outlined how precision radiosurgery and multidisciplinary care are changing AVM treatment. - The message builds on his U.S. fellowship training in stereotactic radiosurgery and cerebrovascular/endovascular neurosurgery. - Dr. Rao said every brain AVM is unique and treatment should be chosen to maximize safety while preserving neurological function and quality of life. - The hospital described the announcement as part of a broader push to translate international research into practical patient guidance.

The details: - A brain AVM is an abnormal tangle of blood vessels in which arteries connect directly to veins without the capillary network in between. - That structure exposes veins to high pressure and raises the risk of rupture and bleeding into the brain. - AVMs are uncommon, but they are an important cause of hemorrhagic stroke, especially in children and younger adults. - Symptoms can include seizures, persistent headaches, weakness, vision changes or sudden neurological decline after intracranial hemorrhage. - AVM treatment choices depend on prior rupture, age, overall health, size, complexity, location, hemorrhage risk, expected neurological impact and patient preferences. - Microsurgery remains the best option for many patients, especially when an AVM can be removed with acceptable risk. - Stereotactic radiosurgery is not conventional surgery; it uses highly focused radiation beams, advanced imaging and submillimeter planning without incisions or skull removal. - Radiation gradually closes abnormal vessels over time, so patients need long-term imaging follow-up until obliteration is confirmed. - Radiosurgery is often used for AVMs that are hard to reach surgically or sit in areas where open surgery could cause higher neurological injury. - Endovascular embolization can reduce blood flow before surgery or radiosurgery, and in some cases it is part of the overall treatment plan. - Careful observation with regular imaging may be the safest choice for a small number of patients whose AVM risk does not justify intervention. - Dr. Rao's hospital said his practice integrates modern diagnostic technology, minimally invasive surgery, stereotactic radiosurgery, endovascular neurosurgery, neurocritical care and multidisciplinary planning. - Dr. Rao's research references included studies on pediatric high-grade AVMs, Spetzler-Martin Grade IV and V AVMs, and international multicenter radiosurgery outcomes. - Those publications support the idea that patient selection, careful planning and long-term follow-up are central to good results. - The hospital said the media contact for the announcement is Dr. Rao's Hospital – International Institute of Neurosciences in Guntur, with website More information.

Between the lines: - The release argues that precision medicine is not just about advanced equipment such as neuronavigation, imaging software or radiosurgery platforms. - The bigger shift is in clinical judgment: matching the treatment to the patient instead of proving one method is best for everyone. - Multidisciplinary review matters because AVMs often require input from neurosurgeons, endovascular specialists, radiation oncologists, neuroradiologists, neurologists, neurocritical care physicians and rehabilitation teams. - That approach can help patients understand not only the benefits of treatment but also the tradeoffs and limits. - The framing also pushes back against online misinformation by stressing that not every AVM needs immediate intervention or open surgery.

What's next: - Patients with new neurological symptoms or a known AVM are being urged to seek prompt evaluation before complications occur. - The release says future AVM decisions should come from experienced multidisciplinary cerebrovascular teams after careful review. - Long-term imaging follow-up remains important regardless of whether the patient chooses surgery, radiosurgery, embolization or observation.

The bottom line: - For brain AVMs, the best outcome depends less on the newest tool and more on choosing the right treatment at the right time for the right patient.